NCT01681966View on ClinicalTrials.gov

A Single-dose Open-Label Study to Assess the Safety and Preliminary Efficacy of PRF 110 in Open Herniorrhaphy Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

May 4, 2016

Study Completion Date

May 4, 2016

Conditions
Post Operative Pain
Interventions
DRUG

PRF110- oily solution (Ropivacaine)

Post operative application of PRF110-oily solution (Ropivacaine)

Trial Locations (3)

2210001

Western Galil Medical Center, Nahariya

Unknown

Assaf Harofeh Medical Center, Rishon LeZiyyon

Sourasky Medical Center, Tel Aviv

Sponsors

Lead Sponsor

PainReform LTD
All Listed Sponsors
lead

PainReform LTD

INDUSTRY

NCT01681966 - A Single-dose Open-Label Study to Assess the Safety and Preliminary Efficacy of PRF 110 in Open Herniorrhaphy Surgery | Biotech Hunter | Biotech Hunter